Sanofi logs six trial updates: new Nuvaxovid, frexalimab, colitis studies and Fabry data lockNov 13Weekly roundup, 10 itemsfexofenadinefrexalimabUpdated
Sanofi's Phase 3 vYF yellow fever vaccine trial in children active, not recruitingNov 6Weekly roundup, 4 itemsbelumosudilcetirizine hydrochloride and pseudoephedrine hydrochloride